Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Temsirolimus is safe in children with neuroblastoma, high-grade glioma and rhabdomyosarcoma

June 25, 2010

New B-raf kinase inhibitors claimed by Korean scientists

June 25, 2010

Sorafenib exhibits antitumor activity in hematological malignancies in phase I trial

June 25, 2010

Eisai's anticancer agent eribulin mesilate receives priority review status in Japan

June 23, 2010

StemEx receives FDA fast track designation

June 23, 2010

OncoGenex begins phase III custirsen sodium trial in metastatic prostate cancer

June 23, 2010

Cellceutix concludes preclinical studies of Kevetrin in multidrug-resistant cancer cells

June 23, 2010

TH-302/doxorubicin combination is safe in phase I/II trial in soft tissue sarcoma

June 23, 2010

Novel PDK1 inhibitors claimed by MSD for cancer therapy

June 23, 2010

Exelixis regains rights to XL-184

June 22, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...